Viewing Study NCT03872427


Ignite Creation Date: 2025-12-25 @ 5:12 AM
Ignite Modification Date: 2026-02-12 @ 10:18 AM
Study NCT ID: NCT03872427
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-14
First Post: 2019-03-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study
Sponsor: National Cancer Institute (NCI)
Organization: